ADVERTISEMENT

Issue Navigator

Volume 14 No. 07
Earn CME
Accepted Papers
Classifieds





Scientific Investigations

Adropin and Inflammation Biomarker Levels in Male Patients With Obstructive Sleep Apnea: A Link With Glucose Metabolism and Sleep Parameters

Josko Bozic, MD, PhD1,2; Josip A. Borovac, MD, BSc1; Tea Galic, DMD, PhD2,3; Tina Ticinovic Kurir, MD, PhD1; Daniela Supe-Domic, PhD4; Zoran Dogas, MD, PhD2,5,6
1Department of Pathophysiology, University of Split School of Medicine, Split, Croatia; 2Department of Neuroscience, University of Split School of Medicine, Split, Croatia; 3Study of Dental Medicine, University of Split School of Medicine, Split, Croatia; 4Department of Medical Laboratory Diagnostics, University Hospital of Split, Split, Croatia; 5Sleep Medicine Center, University of Split School of Medicine, Split, Croatia; 6University Hospital of Split, Split, Croatia

Study Objectives:

The main objectives of the study were to determine plasma adropin, systemic inflammation biomarker levels, and glucose metabolism parameters in patients with moderate and severe obstructive sleep apnea (OSA) compared to healthy controls.

Methods:

In this study, we included 50 male patients with OSA (25 moderate and 25 severe) and 25 age- and sex-matched control subjects. All subjects underwent fasting sampling of peripheral blood for laboratory analyses.

Results:

Adropin plasma levels were significantly lower in the severe OSA group in comparison with the moderate and control groups (4.50 ± 1.45 versus 6.55 ± 1.68 versus 8.15 ± 1.79 ng/mL, P < .001). Plasma biomarkers of systemic inflammation were significantly increased in patients with moderate OSA (interleukin [IL]-6 and tumor necrosis factor alpha [TNF-α]) and severe OSA (IL-6, TNF-α, high-sensitivity C-reactive protein) when compared with controls (P < .001). Adropin levels showed a significant negative correlation with IL-6 (r = −.419, P < .001), TNF-α (r = −.540, P < .001), fasting glucose (r = −.331, P = .004), hemoglobin A1c (r = −.438, P < .001), homeostatic model assessment insulin resistance index (r = −.213, P = .046), and polysomnographic parameters including apnea-hypopnea index (r = −.615, P < .001) and oxygen desaturation index (r = −.573, P < .001). A multivariate regression analysis showed that plasma adropin remained as a significant negative predictor of severe OSA status, when adjusted for age and body mass index and computed along with other inflammatory biomarkers in the regression model (odds ratio 0.069, 95% confidence interval 0.009–0.517, P = .009).

Conclusions:

Plasma adropin concentrations significantly correlate with indices of disease severity in patients with OSA, suggesting that adropin potentially plays an important role in the complex pathophysiology of the disease.

Citation:

Bozic J, Borovac JA, Galic T, Kurir TT, Supe-Domic D, Dogas Z. Adropin and inflammation biomarker levels in male patients with obstructive sleep apnea: a link with glucose metabolism and sleep parameters. J Clin Sleep Med. 2018;14(7):1109–1118.




Please login to continue reading the full article

Subscribers to JCSM get full access to current and past issues of the JCSM.

Login to JCSM

Not a subscriber?

Join the American Academy of Sleep Medicine and receive a subscription to JCSM with your membership

Subscribe to JCSM:  $75/volume year for individuals or $140/volume year for institutions to access all current articles and archives published in JCSM.

Download this article*:   $20 to access a PDF version of a specific article from the current issue of JCSM.

*Purchase of an electronic download of JCSM provides permission to access and print the issue/article for personal scholarly, research and educational use. Please note: access to the article is from the computer on which the article is purchased ONLY. Purchase of the article does not permit distribution, electronic or otherwise, of the article without the written permission of the AASM. Further, purchase does not permit the posting of article text on an online forum or website.